NCT05582785 Low Field Magnetic Resonance Imaging Assessment With Outpatients
| NCT ID | NCT05582785 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Mercy Hospital Kansas City |
| Condition | Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2022-09-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the study is to perform imaging assessments of an early stage magnetic resonance imaging (MRI) system on patients using low field magnetic strength.
Eligibility Criteria
Inclusion Criteria Outpatients at CMH Adele Hall Radiology ages 0 days to 22 years are eligible for enrollment. Exclusion Criteria No additional sedation will be given as part of this study and that sedation, if already administered, will not be altered for study purposes. Any patient who has a contraindication to having an MRI, such as: Non-MRI conditional implanted device or device that is not able to be removed for MRI examination
Contact & Investigator
Sherwin Chan, MD PhD
PRINCIPAL INVESTIGATOR
Children's Mercy
Frequently Asked Questions
Who can join the NCT05582785 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 22 Years, studying Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05582785 currently recruiting?
Yes, NCT05582785 is actively recruiting participants. Contact the research team at mesien@cmh.edu for enrollment information.
Where is the NCT05582785 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT05582785 clinical trial?
NCT05582785 is sponsored by Children's Mercy Hospital Kansas City. The principal investigator is Sherwin Chan, MD PhD at Children's Mercy. The trial plans to enroll 500 participants.